Literature DB >> 12952909

Evidence for a bone-kidney axis regulating phosphate homeostasis.

L Darryl Quarles1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12952909      PMCID： PMC182218          DOI： 10.1172/JCI19687

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  34 in total

1.  Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem.

Authors:  L D Quarles; M K Drezner
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Coordinated maturational regulation of PHEX and renal phosphate transport inhibitory activity: evidence for the pathophysiological role of PHEX in X-linked hypophosphatemia.

Authors:  T Nesbitt; I Fujiwara; R Thomas; Z S Xiao; L D Quarles; M K Drezner
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

3.  FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

Authors:  A E Bowe; R Finnegan; S M Jan de Beur; J Cho; M A Levine; R Kumar; S C Schiavi
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

4.  Hypophosphatemic rickets accompanying McCune-Albright syndrome: evidence that a humoral factor causes hypophosphatemia.

Authors:  T Yamamoto; K I Miyamoto; K Ozono; Y Taketani; K Katai; A Miyauchi; M Shima; H Yoshikawa; K Yoh; E Takeda; S Okada
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

Review 5.  Posttranscriptional regulation of the proximal tubule NaPi-II transporter in response to PTH and dietary P(i).

Authors:  H Murer; I Forster; N Hernando; G Lambert; M Traebert; J Biber
Journal:  Am J Physiol       Date:  1999-11

6.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes.

Authors:  D N Petersen; G T Tkalcevic; A L Mansolf; R Rivera-Gonzalez; T A Brown
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

8.  MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia.

Authors:  P S Rowe; P A de Zoysa; R Dong; H R Wang; K E White; M J Econs; C L Oudet
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

9.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

10.  Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia.

Authors:  M T Collins; C Chebli; J Jones; H Kushner; M Consugar; P Rinaldo; S Wientroub; P Bianco; P G Robey
Journal:  J Bone Miner Res       Date:  2001-05       Impact factor: 6.741
View more
  43 in total

Review 1.  Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism.

Authors:  L Darryl Quarles
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

Review 2.  Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia.

Authors:  Michel Baum; Ashu Syal; Raymond Quigley; Mouin Seikaly
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

3.  Extracellular phosphate alters cementoblast gene expression.

Authors:  R B Rutherford; B L Foster; T Bammler; R P Beyer; S Sato; M J Somerman
Journal:  J Dent Res       Date:  2006-06       Impact factor: 6.116

Review 4.  Regulation of bone remodeling by the central and peripheral nervous system.

Authors:  Florent Elefteriou
Journal:  Arch Biochem Biophys       Date:  2008-03-23       Impact factor: 4.013

Review 5.  Hypophosphatemic rickets: etiology, clinical features and treatment.

Authors:  Vito Pavone; Gianluca Testa; Salvatore Gioitta Iachino; Francesco Roberto Evola; Sergio Avondo; Giuseppe Sessa
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-06-24

6.  Lanthanum carbonate stimulates bone formation in a rat model of renal insufficiency with low bone turnover.

Authors:  Toshio Fumoto; Masako Ito; Kyoji Ikeda
Journal:  J Bone Miner Metab       Date:  2013-10-15       Impact factor: 2.626

Review 7.  The Vestibular System: A Newly Identified Regulator of Bone Homeostasis Acting Through the Sympathetic Nervous System.

Authors:  G Vignaux; S Besnard; P Denise; F Elefteriou
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

Review 8.  Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

Authors:  L Darryl Quarles
Journal:  Exp Cell Res       Date:  2012-03-07       Impact factor: 3.905

Review 9.  Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions.

Authors:  L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

10.  Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.

Authors:  Liping Xiao; Takahiro Naganawa; Joseph Lorenzo; Thomas O Carpenter; J Douglas Coffin; Marja M Hurley
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.